{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:01:28Z","timestamp":1781665288502,"version":"3.54.5"},"reference-count":28,"publisher":"Scientific Scholar","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"abstract":"\n Background & objectives:<\/jats:title>\n Simultaneous administration of phenytoin and isoniazid (INH) in tuberculous meningitis (TBM) or tuberculoma patients with seizures results in higher plasma phenytoin level and thus phenytoin intoxication. N-acetyltransferase 2 (NAT2) enzyme catalyses two acetylation reactions in INH metabolism and NAT2<\/jats:italic> gene polymorphism leads to slow and rapid acetylators. The present study was aimed to evaluate the effect of allelic variants of N<\/jats:italic>-acetyltransferase 2 (NAT2<\/jats:italic>) gene as a predisposing factor for phenytoin toxicity in patients with TBM or tuberculoma having seizures, and taking INH and phenytoin simultaneously.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Sixty patients with TBM or tuberculoma with seizures and taking INH and phenytoin simultaneously for a minimum period of seven days were included in study. Plasma phenytoin was measured by high performance liquid chromatography. NAT2<\/jats:italic> gene polymorphism was studied using restriction fragment length polymorphism and allele specific PCR.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n The patients were grouped into those having phenytoin intoxication and those with normal phenytoin level, and also classified as rapid or slow acetylators by NAT2<\/jats:italic> genotyping. Genotypic analysis showed that of the seven SNPs (single nucleotide polymorphisms) of NAT2<\/jats:italic> gene studied, six mutations were found to be associated with phenytoin intoxication. For rs1041983 (C282T), rs1799929 (C481T), rs1799931 (G857A), rs1799930 (G590A), rs1208 (A803G) and rs1801280 (T341C) allelic variants, the proportion of homozygous mutant was higher in phenytoin intoxicated group than in phenytoin non-intoxicated group.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n Homozygous mutant allele of NAT2<\/jats:italic> gene at 481site may act as a predisposing factor for phenytoin intoxication among TBM or tuberculoma patients having seizures.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/0971-5916.187106","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T04:42:37Z","timestamp":1470285757000},"page":"581-590","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["N-acetyltransferase 2 (NAT2) gene polymorphism as a predisposing factor for phenytoin intoxication in tuberculous meningitis or tuberculoma patients having seizures - A pilot study"],"prefix":"10.25259","volume":"143","author":[{"given":"Prashant S.","family":"Adole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parampreet S.","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-8-20241212","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jinf.2004.02.010","article-title":"Tuberculous meningitis and miliary tuberculosis: The Rich focus revisited","volume":"50","author":"Donald","year":"2005","journal-title":"J Infect"},{"key":"R2-8-20241212","first-page":"33","article-title":"Tuberculous meningitis in patients without systemic focus of miliary tuberculosis","volume":"2","author":"Kashyap","year":"2007","journal-title":"Am-Eura J Sci Res"},{"key":"R3-8-20241212","first-page":"9","article-title":"Estimating mortality from tuberculous meningitis in a community: use of available epidemiological parameters in the Indian context","volume":"47","author":"Chakraborty","year":"2000","journal-title":"Indian J Tuberc"},{"key":"R4-8-20241212","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3476(75)80066-7","article-title":"Tuberculous meningitis in children during the isoniazid era","volume":"87","author":"Sumaya","year":"1975","journal-title":"J Pediatr"},{"key":"R6-8-20241212","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/tropej\/42.2.98","article-title":"Long-term anticonvulsant therapy in tuberculous meningitis-a four-year follow-up","volume":"42","author":"Patwari","year":"1996","journal-title":"J Trop Pediatr"},{"key":"R7-8-20241212","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/0006-2952(81)90393-2","article-title":"Mechanism of the inhibitory action of isoniazid on microsomal drug metabolism","volume":"30","author":"Muakkassah","year":"1981","journal-title":"Biochem Pharmacol"},{"key":"R8-8-20241212","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2131\/jts.33.187","article-title":"Effects of N-acetyltransferase (NAT-2), CYP2E1 and glutathione-s-transferase (GST) genotype on serum concentration of isoniazid and its metabolites in tuberculosis patients","volume":"33","author":"Fukino","year":"2008","journal-title":"J Toxicol Sci"},{"key":"R9-8-20241212","first-page":"29","article-title":"Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms","volume":"9","author":"Hein","year":"2000","journal-title":"Can Epi Bio Prev"},{"key":"R10-8-20241212","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00228-001-0396-3","article-title":"Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes","volume":"57","author":"Wen","year":"2002","journal-title":"Eur J Clin Phramacol"},{"key":"R11-8-20241212","first-page":"1175","article-title":"Phenytoin toxicity due to concomitant antituberculosis therapy","volume":"85","author":"Walubo","year":"1995","journal-title":"S Afr Med J"},{"key":"R12-8-20241212","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/gut.52.suppl_2.ii10","article-title":"Pharmacogenomics: marshalling the human genome to individualize drug therapy","volume":"52","author":"Evans","year":"2003","journal-title":"Gut"},{"key":"R13-8-20241212","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1098\/rstb.2005.1693","article-title":"Pharmacogenetics in drug regulation: promise, potential and pitfalls","volume":"360","author":"Shah","year":"2005","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R14-8-20241212","first-page":"125","article-title":"Aryl amine N-acetyltransferase 2 polymorphism in the ethnic population of South Indians","volume":"11","author":"Anitha","year":"2003","journal-title":"Int J Mol Med"},{"key":"R15-8-20241212","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2490-5-12","article-title":"Genetic polymorphism of the N-acetyltransferase 2 gene and susceptibility to prostate cancer: a pilot study in north Indian population","volume":"5","author":"Srivastava","year":"2005","journal-title":"BMC Urol"},{"key":"R16-8-20241212","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03256314","article-title":"Study of NAT2 gene polymorphisms in an Indian population: association with plasma isoniazid concentration in a cohort of tuberculosis patients","volume":"13","author":"Singh","year":"2009","journal-title":"Mol Diagn Ther"},{"key":"R17-8-20241212","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejphar.2013.05.032","article-title":"Phenotypic interaction of simultaneously administered isoniazid and phenytoin in patients with tuberculous meningitis or tuberculoma having seizures","volume":"714","author":"Adole","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"R19-8-20241212","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/qjmed\/91.5.325","article-title":"Features and management of poisoning with modern drugs used to treat epilepsy","volume":"91","author":"Jones","year":"1998","journal-title":"Q J Med"},{"key":"R20-8-20241212","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0076-6879(96)72024-4","article-title":"CYP2D6 multi allelism","volume":"272","author":"Daly","year":"2001","journal-title":"Methods Enzymol"},{"key":"R21-8-20241212","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/pgs.13.2","article-title":"NAT2 sequence polymorphisms and acetylation profiles in Indians","volume":"14","author":"Khan","year":"2013","journal-title":"Pharmacogenomics"},{"key":"R22-8-20241212","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00008571-199406000-00003","article-title":"Ethnic distribution of slow acetylator mutation in the polymorphic N-acetyltransferase (NAT-2) gene","volume":"4","author":"Lin","year":"1994","journal-title":"Pharmacogenetics"},{"key":"R23-8-20241212","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00008571-199712000-00009","article-title":"Meta analysis of phenotype and genotype of NAT-2 deficiency in Chinese population","volume":"7","author":"Xie","year":"1997","journal-title":"Pharmacogenetics"},{"key":"R24-8-20241212","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00008571-199702000-00010","article-title":"Polymorphic N-acetyltransferse (NAT-2) genotyping of Emiratis","volume":"7","author":"Woolhouse","year":"1997","journal-title":"Pharmacogenetics"},{"key":"R25-8-20241212","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1755-5949.2011.00291.x","article-title":"Genetic polymorphism of NAT2 metabolizing enzymes on phenytoin pharmacokinetics in Indian epileptic patients developing toxicity","volume":"18","author":"Murali","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"R26-8-20241212","first-page":"581","article-title":"Arylamine N- acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: Correlation with phenotypic activity","volume":"57","author":"Cascorbi","year":"1995","journal-title":"Am J Hum Genet"},{"key":"R27-8-20241212","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/carcin\/14.8.1689","article-title":"Genotype\/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African- Americans","volume":"14","author":"Bell","year":"1993","journal-title":"Carcinogenesis"},{"key":"R28-8-20241212","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/138920008784892065","article-title":"Structure\/function evaluations of single nucleotide polymorphisms in human N-Acetyltransferase 2","volume":"9","author":"Walraven","year":"2008","journal-title":"Curr Drug Metab"},{"key":"R29-8-20241212","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/aje\/kwm167","article-title":"Joint Effects of the N-Acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: A literature-based systematic huge review and evidence synthesis","volume":"166","author":"Sanderson","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R30-8-20241212","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/sj.onc.1209374","article-title":"N-acetyltransferase 2 genetic polymorphism: Effects of carcinogen and haplotype on urinary bladder cancer risk","volume":"25","author":"Hein","year":"2006","journal-title":"Oncogene"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201643050-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:57:37Z","timestamp":1751497057000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/n-acetyltransferase-2-nat2-gene-polymorphism-as-a-predisposing-factor-for-phenytoin-intoxication-in-tuberculous-meningitis-or-tuberculoma-patients-having-seizures-a-pilot-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/0971-5916.187106","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}